The world is being quietly rearranged by people who write very long documents.


The title they went with Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Anti-Mullerian Hormone Test System Noisy translates that to

Fertility clinics can now use a new test to predict IVF success


US health regulators have made it easier to bring a new type of fertility test to market. This means doctors and patients will have more options to predict the success of in-vitro fertilization (IVF) treatments.
For years, fertility clinics relied on a limited set of tools to assess a woman's ovarian reserve and predict IVF outcomes. This regulatory change opens the door for new diagnostic tests to be widely adopted. It means patients undergoing IVF may get more precise information about their chances of success, potentially reducing the emotional and financial burden of multiple failed cycles.
Watch for new anti-Mullerian hormone (AMH) test systems to appear on the market and for fertility clinics to begin offering them as a standard part of IVF consultation.

If you insist
Read the original →